Companies / BOC Sciences / Otilimab
BOC Sciences

Otilimab | BOC Sciences

Otilimab is a human monoclonal antibody directed against the granulocyte-macrophage colony stimulating factor (GM-CSF). Otilimab has been used in the research of moderate to severe rheumatoid arthritis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.